Innovent Biologics, a biopharmaceutical company in SIP, wrapped up its three-month weight loss challenge themed “Scientific Weight Loss, Health for All” on Nov 6. Thanks to mutual support in three-member teams and scientific approaches, the participating employees lost weight totaling 686.6 kilograms.

Founded in SIP in 2011 and listed on the Hong Kong Stock Exchange in 2018, Innovent Biologics is dedicated to developing innovative drugs for diseases such as those for cancers and metabolic and autoimmune diseases.

The company has established a comprehensive support system, including 11 health stations equipped with smart scales and waist measurement tools, alongside a upgraded staff canteen offering nutritionist-designed meals. Free chicken salads are provided for employees with BMI (Body Mass Index) ≥ 27.

It is worth mentioning that the company has independently developed the Mazdutide Injection, which is the world’s first dual GLP-1/glucagon (GCP) receptor agonist available in market for chronic weight management in adults who are overweight or have obesity.

November 7, 2025